Manulife (Manufacturers Life Insurance)’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$125K Buy
100,914
+2,798
+3% +$3.47K ﹤0.01% 2711
2025
Q1
$116K Sell
98,116
-194,343
-66% -$229K ﹤0.01% 2663
2024
Q4
$535K Sell
292,459
-2,906
-1% -$5.32K ﹤0.01% 2202
2024
Q3
$502K Sell
295,365
-34,450
-10% -$58.6K ﹤0.01% 2289
2024
Q2
$452K Buy
329,815
+15,567
+5% +$21.3K ﹤0.01% 2259
2024
Q1
$1.18M Sell
314,248
-12,229
-4% -$45.9K ﹤0.01% 1770
2023
Q4
$3.2M Sell
326,477
-5,569
-2% -$54.6K ﹤0.01% 1328
2023
Q3
$2.77M Buy
332,046
+48,740
+17% +$407K ﹤0.01% 1337
2023
Q2
$3.77M Buy
283,306
+9,930
+4% +$132K ﹤0.01% 1212
2023
Q1
$3.17M Buy
273,376
+20,047
+8% +$232K ﹤0.01% 1255
2022
Q4
$2.09M Sell
253,329
-626
-0.2% -$5.17K ﹤0.01% 1367
2022
Q3
$1.44M Sell
253,955
-2,897
-1% -$16.4K ﹤0.01% 1473
2022
Q2
$1.16M Buy
256,852
+10,710
+4% +$48.4K ﹤0.01% 1587
2022
Q1
$2.33M Buy
246,142
+147,698
+150% +$1.4M ﹤0.01% 1461
2021
Q4
$2.04K Sell
98,444
-254
-0.3% -$5 ﹤0.01% 1495
2021
Q3
$2.52M Sell
98,698
-9,616
-9% -$246K ﹤0.01% 1444
2021
Q2
$3.79M Buy
108,314
+6,749
+7% +$236K ﹤0.01% 1393
2021
Q1
$3.38M Sell
101,565
-3,262
-3% -$109K ﹤0.01% 1389
2020
Q4
$2.72M Buy
104,827
+10,149
+11% +$263K ﹤0.01% 1428
2020
Q3
$934K Buy
94,678
+6,292
+7% +$62.1K ﹤0.01% 1690
2020
Q2
$305K Sell
88,386
-4,019
-4% -$13.9K ﹤0.01% 2243
2020
Q1
$283K Buy
92,405
+6,432
+7% +$19.7K ﹤0.01% 2127
2019
Q4
$442K Sell
85,973
-2,183
-2% -$11.2K ﹤0.01% 2122
2019
Q3
$460K Sell
88,156
-139
-0.2% -$725 ﹤0.01% 2070
2019
Q2
$534K Sell
88,295
-1,636
-2% -$9.89K ﹤0.01% 2012
2019
Q1
$650K Buy
89,931
+9,126
+11% +$66K ﹤0.01% 1927
2018
Q4
$598K Sell
80,805
-1,362
-2% -$10.1K ﹤0.01% 1867
2018
Q3
$445K Sell
82,167
-13,174
-14% -$71.3K ﹤0.01% 2371
2018
Q2
$338K Buy
95,341
+3,418
+4% +$12.1K ﹤0.01% 2691
2018
Q1
$189K Buy
91,923
+7,743
+9% +$15.9K ﹤0.01% 3061
2017
Q4
$223K Buy
84,180
+2,147
+3% +$5.69K ﹤0.01% 2917
2017
Q3
$431K Buy
82,033
+11,500
+16% +$60.4K ﹤0.01% 2380
2017
Q2
$250K Buy
70,533
+5,145
+8% +$18.2K ﹤0.01% 2829
2017
Q1
$339K Buy
65,388
+9,030
+16% +$46.8K ﹤0.01% 2460
2016
Q4
$215K Buy
56,358
+3,669
+7% +$14K ﹤0.01% 2727
2016
Q3
$473K Sell
52,689
-679
-1% -$6.1K ﹤0.01% 2121
2016
Q2
$376K Buy
53,368
+11,920
+29% +$84K ﹤0.01% 2221
2016
Q1
$362K Sell
41,448
-2,777
-6% -$24.3K ﹤0.01% 2189
2015
Q4
$580 Buy
44,225
+420
+1% +$6 ﹤0.01% 1931
2015
Q3
$161 Buy
43,805
+445
+1% +$2 ﹤0.01% 2821
2015
Q2
$250 Buy
43,360
+3,975
+10% +$23 ﹤0.01% 2675
2015
Q1
$230 Buy
39,385
+1,484
+4% +$9 ﹤0.01% 2630
2014
Q4
$297 Sell
37,901
-547
-1% -$4 ﹤0.01% 2357
2014
Q3
$189 Buy
38,448
+157
+0.4% +$1 ﹤0.01% 2679
2014
Q2
$237K Buy
38,291
+135
+0.4% +$836 ﹤0.01% 2597
2014
Q1
$204 Sell
38,156
-1,386
-4% -$7 ﹤0.01% 2699
2013
Q4
$207 Buy
39,542
+38,142
+2,724% +$200 ﹤0.01% 2694
2013
Q3
$8 Buy
1,400
+440
+46% +$3 ﹤0.01% 3289
2013
Q2
$2K Buy
+960
New +$2K ﹤0.01% 3411